Stock Information
Climb Bio Inc (CLYM)
Ticker Symbol: CLYM
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $447.29 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -0.8826
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -33.41%
Latest News
-
Climb Bio: 'Buy' On Budoprutug Phase 2 Advancement pMN And Expansions Underway
Thu, Apr 16, 2026 2:14 PM
-
Mizuho Initiates Coverage On Climb Bio with Outperform Rating, Announces Price Target of $18
Wed, Apr 15, 2026 5:20 AM
Key Financials
Financial data not available
